View of Study of V-Domain Immunoglobulin Inhibitor of T-Cell Activation Marker in Iraqi Patients with Diabetes Mellitus Type-1

Return to Article Details Study of V-Domain Immunoglobulin Inhibitor of T-Cell Activation Marker in Iraqi Patients with Diabetes Mellitus Type-1 Download Download PDF